Program improves compliance with heart attack guidelines.
Levenson
Deborah
D
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017130:Angioplasty; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D019468:Disease Management; D019983:Guideline Adherence; D006334:Heart Function Tests; D006761:Hospitals / Q000592:standards; D006801:Humans; D008824:Michigan; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000628:therapy; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D017010:Reminder Systems; D016540:Smoking Cessation; D014481:United States
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin